SHANGHAI and WARREN, N.J., April 7, 2024 /PRNewswire/ — Laekna (2105.HK) announced that the company has presented two internally-discovered preclinical candidates, in addition to a poster presentation on a clinical trial, at the 2024 Annual Meeting of the American Association for Cancer…



Leave a Reply

Your email address will not be published. Required fields are marked *